FindTrial
Sign In

Role of Shirishadi kwath in management of Asthma

Clinicopathological study of tamak shwas and therapeautic evaluation of an Ayurvedic formulation in its management.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013336
Enrollment
40
Registered
2018-04-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patient diagnosed with Asthma

Interventions

Intervention1: Shirishadi kwath: 50 ml twice a day after meal for 60 days Control Intervention1: not applicable: not applicable

Sponsors

Campus Director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having the classical symtoms of tamaka shwasa will be included

Exclusion criteria

Exclusion criteria: 1.Patients of cardiac asthma, COPD, emphysema, post tubercular lung fibrosis. 2.Patients having any other systemic disorder like diabetes, HTN, tuberculosis etc

Design outcomes

Primary

MeasureTime frame
The Trail Yet to be StartedTimepoint: June 2019—

Secondary

MeasureTime frame
the trial have not started yetTimepoint: the trial have not started yet—

Countries

India

Contacts

Public ContactSanjay kumar singh

Rishikul campus UAU Haridwar

drsanjaysingh1970@gmail.com9415284453

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026